![John Cullity](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Cullity
Presidente presso
HaemaLogiX Pty Ltd.
Patrimonio netto: 4 M $ in data 30/06/2026
Profilo
John Cullity is currently the Chairman at HaemaLogiX Pty Ltd. He is also a Director at Theraly Fibrosis, Inc. and a Managing Director at Biosynergy Partners LLC.
Additionally, he is a Member at The Royal College of Physicians.
In his former positions, Dr. Cullity served as a Director of Health Economics at Merk Sharp & Dohme (Holdings) Pty Ltd. and Sanofi-Aventis Healthcare Pty Ltd. He was also a Non-Executive Director at Race Oncology Ltd. from 2018 to 2023 and a Director at Ceramedix Holdings LLC from 2015 to 2020.
Furthermore, he held the position of Senior Member-Business Development at Sanofi-Synthelabo, Inc. and worked as a Principal at Torreya Partners LLC from 2010 to 2017.
Dr. Cullity obtained a graduate degree from the London School of Economics & Political Science.
He also holds an undergraduate degree from The University of Western Australia and an MBA from The Wharton School of the University of Pennsylvania.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
RACURA ONCOLOGY LTD 1,37% | 08/08/2025 | 2.694.642 ( 1,37% ) | 4 M $ | 30/06/2026 |
Posizioni attive di John Cullity
| Società | Posizione | Inizio |
|---|---|---|
Biosynergy Partners LLC | Corporate Officer/Principal | 01/09/2013 |
Theraly Fibrosis, Inc.
 Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Direttore/Membro del Consiglio | 01/09/2016 |
HaemaLogiX Pty Ltd.
 HaemaLogiX Pty Ltd. BiotechnologyHealth Technology Develops immunotherapies for blood cancers and B cell disorders | Presidente | - |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Precedenti posizioni note di John Cullity
| Società | Posizione | Fine |
|---|---|---|
| RACURA ONCOLOGY LTD | Presidente | 20/04/2023 |
Ceramedix Holdings LLC
 Ceramedix Holdings LLC Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutics company that develops antibody-based drugs | Direttore/Membro del Consiglio | 01/03/2020 |
Torreya Partners LLC
 Torreya Partners LLC Investment ManagersFinance Provides financial advisory services | Corporate Officer/Principal | 01/01/2017 |
Sanofi-Aventis Healthcare Pty Ltd. | Corporate Officer/Principal | - |
Merk Sharp & Dohme (Holdings) Pty Ltd.
 Merk Sharp & Dohme (Holdings) Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals products | Corporate Officer/Principal | - |
Formazione di John Cullity
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
84
Relazioni di 1° grado
13
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
London School of Economics & Political Science
 London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Western Australia
 The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Synthelabo, Inc. | Health Technology |
Merk Sharp & Dohme (Holdings) Pty Ltd.
Merk Sharp & Dohme (Holdings) Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals products | Health Technology |
Torreya Partners LLC
Torreya Partners LLC Investment ManagersFinance Provides financial advisory services | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis Healthcare Pty Ltd. | |
Race Oncology Ltd.
 Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
HaemaLogiX Pty Ltd.
HaemaLogiX Pty Ltd. BiotechnologyHealth Technology Develops immunotherapies for blood cancers and B cell disorders | Health Technology |
Biosynergy Partners LLC | |
Ceramedix Holdings LLC
Ceramedix Holdings LLC Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutics company that develops antibody-based drugs | Health Technology |
